BR112012014941A2 - composição compreendendo uam forma vítrea não cristalina e amorfa de roxitromicina - Google Patents

composição compreendendo uam forma vítrea não cristalina e amorfa de roxitromicina

Info

Publication number
BR112012014941A2
BR112012014941A2 BR112012014941A BR112012014941A BR112012014941A2 BR 112012014941 A2 BR112012014941 A2 BR 112012014941A2 BR 112012014941 A BR112012014941 A BR 112012014941A BR 112012014941 A BR112012014941 A BR 112012014941A BR 112012014941 A2 BR112012014941 A2 BR 112012014941A2
Authority
BR
Brazil
Prior art keywords
roxithromycin
crystalline
composition
amorphous glass
glass form
Prior art date
Application number
BR112012014941A
Other languages
English (en)
Inventor
Marique Aucamp
Melgardt M De Villiers
Wilna Liebenberg
Original Assignee
Univ Northwest
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Northwest filed Critical Univ Northwest
Publication of BR112012014941A2 publication Critical patent/BR112012014941A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
BR112012014941A 2009-12-18 2010-12-15 composição compreendendo uam forma vítrea não cristalina e amorfa de roxitromicina BR112012014941A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200909098 2009-12-18
PCT/IB2010/055841 WO2011073926A1 (en) 2009-12-18 2010-12-15 Composition comprising an amorphous non- crystalline glass form of roxithromycin

Publications (1)

Publication Number Publication Date
BR112012014941A2 true BR112012014941A2 (pt) 2015-09-15

Family

ID=43709135

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112012014941A BR112012014941A2 (pt) 2009-12-18 2010-12-15 composição compreendendo uam forma vítrea não cristalina e amorfa de roxitromicina
BR112012014926A BR112012014926A2 (pt) 2009-12-18 2010-12-15 composição compreendendo uma forma vítrea não cristalina e amorfa de azitromicina

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR112012014926A BR112012014926A2 (pt) 2009-12-18 2010-12-15 composição compreendendo uma forma vítrea não cristalina e amorfa de azitromicina

Country Status (12)

Country Link
US (2) US8901089B2 (pt)
EP (2) EP2513130B1 (pt)
JP (1) JP2013514346A (pt)
KR (1) KR20120107989A (pt)
CN (2) CN102822187B (pt)
AP (1) AP2012006312A0 (pt)
AU (2) AU2010331867A1 (pt)
BR (2) BR112012014941A2 (pt)
CA (2) CA2784497A1 (pt)
RU (1) RU2012130435A (pt)
WO (2) WO2011073927A1 (pt)
ZA (2) ZA201204409B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102286045B (zh) * 2011-09-07 2013-08-07 山东罗欣药业股份有限公司 罗红霉素一水合物结晶、其制备方法及含该结晶和盐酸氨溴索组合的组合物干混悬剂
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
CN106589022B (zh) * 2016-11-16 2019-06-18 山东裕欣药业有限公司 一种罗红霉素化合物及其制备方法、药物组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998005674A1 (en) * 1996-08-07 1998-02-12 Russinsky Limited Process for the production of salts of erythromycin, roxithromycin, clarithromycin and azithromycin
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
DE69915327T2 (de) * 1998-10-20 2005-02-10 Russinsky Ltd. Derivate des erythromycins, des clarithromycins, des roxithromycins oder des azithromycin mit antibiotischer und mucolytischer wirkung
ES2177373B1 (es) 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
EP1671978A1 (en) * 2001-05-22 2006-06-21 Pfizer Products Inc. New Cristal Form of Azithromycin
HRP20020614A2 (en) * 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
JP2009501206A (ja) * 2005-07-14 2009-01-15 ファイザー・プロダクツ・インク 非晶質アジスロマイシン粒子の生成方法

Also Published As

Publication number Publication date
WO2011073926A1 (en) 2011-06-23
ZA201204411B (en) 2013-02-27
EP2513130A1 (en) 2012-10-24
AU2010331866A1 (en) 2012-07-12
US20130045936A1 (en) 2013-02-21
JP2013514346A (ja) 2013-04-25
EP2513129A1 (en) 2012-10-24
WO2011073927A1 (en) 2011-06-23
US20130059805A1 (en) 2013-03-07
KR20120107989A (ko) 2012-10-04
CN102822187A (zh) 2012-12-12
EP2513130B1 (en) 2016-05-25
AP2012006312A0 (en) 2012-06-30
CN102712670A (zh) 2012-10-03
BR112012014926A2 (pt) 2015-09-15
CA2784494A1 (en) 2011-06-23
RU2012130435A (ru) 2014-01-27
AU2010331867A1 (en) 2012-07-12
CA2784494C (en) 2019-03-12
CA2784497A1 (en) 2011-06-23
CN102822187B (zh) 2015-05-20
US8901089B2 (en) 2014-12-02
ZA201204409B (en) 2013-02-27

Similar Documents

Publication Publication Date Title
BRPI1008037A2 (pt) composição de espuma tópica
UY33146A (es) Proceso de biodegradacion y composicion
BRPI1006125A2 (pt) óculos
DE112010003410T8 (de) Vorkammerzündkerze
IT1399031B1 (it) Copoliestere alifatico-aromatico biodegradabile
BRPI1010079A2 (pt) composição e artigo
DK2479265T3 (da) Glucoamylasevarianter med ændrede egenskaber
DK2479264T3 (da) Glucoamylasevarianter med ændrede egenskaber
BR112012002247A2 (pt) composição e artigo
BR112012005321A2 (pt) processo e composição
BR112012005347A2 (pt) vedação de friso de vidro de núcleo sólido com nervura de reforço
BRPI1008788A2 (pt) material de isolamento térmico compreendendo sílica precipitada
DK2246477T3 (da) Spunspæl med dobbelt t-form
FI20090057A0 (fi) Antibakteerinen lasi
BR112012014941A2 (pt) composição compreendendo uam forma vítrea não cristalina e amorfa de roxitromicina
BR112012003641A2 (pt) composição e processo
ZA201207441B (en) Amorphous roxithromycin composition
BRPI0917753A2 (pt) vidro antirreflexo
FR2954764B1 (fr) Creuset en silice
BR112012015370A2 (pt) artigo higiênico
BRPI1013935A2 (pt) composicao oral
FR2947871B1 (fr) Barriere anti-condensation sur circuit regeneratif
FR2946526B1 (fr) Sterilet
ITDP20090020U1 (it) Cravatta pulisci occhiali
TH137154B (th) องค์ประกอบและวิธีการทำความสะอาด

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2609 DE 05-01-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.